| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |